Economic Value of Changing Mortality Risk
2021
This article develops a framework for quantifying monetary values associated with changes in disease-specific mortality risk in low- and middle- income countries to help quantify trade-offs involved in investing in mortality reduction due to one disease versus another.
For non-communicable diseases, the absolute monetary value associated with changing mortality risk was highest for cardiovascular diseases in older age groups. Changing the mortality rate from the base-case to the high-performance trajectory was associated with high monetary value for communicable diseases as well, especially among younger age groups.
The article’s framework provides a priority setting paradigm to best allocate investments toward the health sector and enables intersectoral comparisons of returns on investments from health interventions.
Economic Value of Changing Mortality Risk
Source:
Khadka A, Verguet S. The Economic Value of Changing Mortality Risk in Low-and Middle-Income Countries: A Systematic Breakdown by Cause of Death. BMC Medicine 2021; 19 (1): 1-11. https://doi.org/10.1186/s12916-021-02029-x